Biology Reference
In-Depth Information
Raf-1/mitogen-activated protein kinase signal transduction pathway.
J Virol
72: 919-925
37 Nishigaki K, Hanson C, Ohashi T, Thompson D, Muszynski K, Ruscetti S (2000) Erythroid cells
rendered erythropoietin independent by infection with Friend spleen focus-forming virus show
constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: Involvement of insulin
receptor substrate-related adapter proteins.
J Virol
74: 3037-3045
38 Constantinescu SN, Ghaffari S, Lodish HF (1999) The erythropoietin receptor: Structure, activa-
tion and intracellular signal transduction.
Trends Endocrinol Metab
10: 18-23
39 Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, Leeder JS, Freedman M,
Cohen A, Gazit A et al. (1996) Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor.
Nature
379: 645-648
40 Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lessard M,
Berger R, Ghysdael J et al. (1997) A TEL-JAK 2 fusion protein with constitutive kinase activity
in human leukemia.
Science
278: 1309-1312
41 Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey
L, Baens M, Van den Berghe H et al. (1997) Fusion of TEL, the ETS-variant gene 6 (ETV6), to
the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a
myeloid leukemia.
Blood
90: 2535-2540
42 Hanratty WP, Dearolf CR (1993) The drosophila tumorous-lethal hematopoietic oncogene is a
dominant mutation in the hopscotch locus.
Mol Gen Genet
238: 33-37
43 Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S,
Colamonici OR, van Deursen JM et al. (1998) Jak2 is essential for signaling through a variety of
cytokine receptors.
Cell
93: 385-395
44 Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, Pfeffer K (1998) Jak2 deficiency defines
an essential developmental checkpoint in definitive hematopoiesis.
Cell
93: 397-409
45 Hilton DJ, Watowich SS, Murray PJ, Lodish HF (1995) Increased cell surface expression and
enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor.
Proc Natl
Acad Sci USA
92: 190-194
46 Broudy VC, Lin N, Brice M, Nakamoto B, Papayannopoulou T (1991) Erythropoietin receptor
characteristics on primary human erythroid cells.
Blood
77: 2583-2590
47 Sawyer ST, Krantz SB, Luna J (1987) Identification of the receptor for erythropoietin by cross-
linking to Friend virus-infected erythropoietin cells.
Proc Natl Acad Sci USA
84: 3690-3694
48 Huang LJ, Constantinescu SN, Lodish HF (2001) The N-terminal domain of Janus kinase 2 is
required for Golgi processing and cell surface expression of erythropoietin receptor.
Mol Cell
8:
1327-1338
49 Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN (1993) JAK2 associ-
ates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stim-
ulation with erythropoietin.
Cell
74: 227-236
50 Feng J, Witthuhn BA, Matsuda T, Kohlhuber F, Kerr IM, Ihle JN (1997) Activation of Jak2 cat-
alytic activity requires phosphorylation of Y1007 in the kinase activation loop.
Mol Cell Biol
17:
2497-2501
51 Miller CP, Heilman DW, Wojchowski DM (2002) Erythropoietin receptor-dependent erythroid
colony-forming unit development: Capacities of Y343 and phosphotyrosine-null receptor forms.
Blood
99:898-904
52 Zang H, Sato K, Nakajima H, McKay C, Ney PA, Ihle JN (2001) The distal region and receptor
tyrosines of the EPO receptor are non-essential for
in vivo
erythropoiesis.
EMBO J
20: 3156-3166
53 Ghaffari S, Kitidis C, Fleming MD, Neubauer H, Pfeffer K, Lodish HF (2001) Erythropoiesis in
the absence of janus-kinase2: BCR-ABL induces red cell formation in JAK2(-/-) hematopoietic
progenitors.
Blood
98: 2948-2957
54 Klingmuller U, Bergelson S, Hsiao JG, Lodish HF (1996) Multiple tyrosine residues in the cytoso-
lic domain of the erythropoietin receptor promote activation of STAT5.
Proc Natl Acad Sci USA
93: 8324-8328
55 Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N, Miura O (1998) Lyn physically associates
with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Blood
91:
3734-3745
56 Duprez V, Blank U, Chretien S, Gisselbrecht S, Mayeux P (1998) Physical and functional inter-
action between p72(syk) and erythropoietin receptor.
J Biol Chem
273: 33985-33990
57 Machide M, Mano H, Todokoro K (1995) Interleukin 3 and erythropoietin induce association of
Vav with Tec kinase through Tec homology domain.
Oncogene
11: 619-625
